Welcome to our dedicated page for Terrascent news (Ticker: TSNDF), a resource for investors and traders seeking the latest updates and insights on Terrascent stock.
TerrAscend Corp. issues news as a North American cannabis operator with common shares traded on the TSX as TSND and on OTCQX as TSNDF. Coverage centers on financial results from continuing operations, retail and wholesale cannabis revenue, gross margin, EBITDA, cash flow, and capital allocation.
The company operates The Apothecarium and other dispensary locations, along with cultivation, processing, and manufacturing facilities in Pennsylvania, New Jersey, Maryland, Ohio, California, and Canadian retail. Recurring updates also cover brand licensing and product launches involving names such as Cookies, Kind Tree, Wana, Valhalla Confections, and TYSON 2.0, as well as refinancings, acquisitions, share repurchase activity, discontinued operations, and executive appointments.
TerrAscend (OTCQX: TSNDF) reported the results of its special meeting of shareholders held on August 24, 2026. Common shareholders approved a special resolution to amend the company’s articles to enable a share consolidation, referred to as the Share Consolidation Resolution.
The resolution received strong support, with 143,095,552 votes (99.25%) cast in favor and 141,435 votes (0.10%) withheld. The company said this approval completes a key step in its preparation to list on a major U.S. stock exchange.
TerrAscend (OTCQX: TSNDF, TSX: TSND) announced that its board has renewed and replenished a normal course issuer bid authorizing repurchases of up to USD $10 million of common shares over a 12‑month period starting August 24, 2026 and ending no later than August 23, 2027.
According to TerrAscend, the program allows the company to use excess cash to buy back up to 10,000,000 shares, or 3.23% of the 309,175,647 shares outstanding as of August 13, 2026, subject to a daily limit of 58,784 shares. The company does not expect to incur debt to fund the repurchases and is under no obligation to buy any shares. All repurchased shares will be cancelled, and ATB Cormark Capital Markets has been re‑appointed as designated broker. Under the previous NCIB begun in 2025, TerrAscend bought 653,500 shares for about $417,371 (CAD$579,165) at a volume‑weighted average price of $0.64 (CAD$0.89).
TerrAscend (OTCQX: TSNDF, TSX: TSND) reported Q2 2026 net revenue of $67.1 million, up from $65.5 million in Q1 2026 and $65.0 million in Q2 2025. Gross profit margin from continuing operations rose to 54.0%, while GAAP net loss from continuing operations widened to $10.1 million.
Adjusted EBITDA from continuing operations was $17.7 million (26.3% margin), with net cash provided from continuing operations of $7.4 million and free cash flow of $5.7 million, marking the 16th consecutive positive operating cash flow quarter and 12th for free cash flow. Cash and equivalents were $42.0 million.
The company completed an oversubscribed $21.8 million convertible debenture financing, used $11.1 million to retire higher‑interest debentures and extended most convertible maturities to 2031, and repaid $10.0 million on its term loan in Q2. TerrAscend also agreed to an option to acquire Aunt Mary’s dispensary in New Jersey and scheduled an August 24, 2026 special shareholder meeting to vote on a proposed share consolidation related to a potential major U.S. exchange listing.
TerrAscend (OTCQX: TSNDF, TSX: TSND) will host a second quarter 2026 earnings conference call on Thursday, August 6, 2026 at 5:00 p.m. Eastern Time to discuss results for the quarter ended June 30, 2026. Financial results will be released that same day after market close.
TerrAscend (OTCQX:TSNDF) signed an option agreement to acquire its fifth New Jersey dispensary, Aunt Mary’s in Hunterdon County. The store generates over $10 million in annualized revenue and is expected to be immediately accretive to EBITDA and free cash flow.
The total purchase price is $9 million, including a $3 million five-year unsecured 6.0% convertible note for a 35% option and $6 million cash on exercise. Closing depends on standard conditions, including regulatory approval.
TerrAscend (OTCQX: TSNDF) filed a preliminary proxy for a Special Meeting of shareholders on August 24, 2026, with a record date of June 30, 2026.
Voting shareholders will consider a share consolidation within a 1-for-5 to 1-for-20 range to help meet major U.S. exchange listing requirements.
TerrAscend (OTCQX: TSNDF) closed an oversubscribed private placement of senior secured convertible debentures totaling $21.7 million. About $11.1 million retired higher-rate senior unsecured convertible debt, with remaining funds earmarked for mergers and acquisitions.
The debentures mature on September 30, 2031, pay 8% interest, and are convertible at US$0.87, a 25% premium to the 20-day VWAP. The notes are secured by a second lien on the U.S. business. An insider purchased 1,000 debentures for US$1 million, treated as a related party transaction under MI 61-101.
TerrAscend (OTCQX: TSNDF) reported voting results from its June 9, 2026 annual general meeting. Shareholders re-elected five directors, each receiving at least 96.75% support. MNP LLP was re-appointed as auditor with 99.78% of votes. Equity incentive plans also passed with about 99% approval.
TerrAscend (OTCQX: TSNDF) has called a Special Meeting of Shareholders for August 24, 2026 to vote on a share consolidation of its common shares. The move is intended to help the company meet share-price criteria for a potential uplisting to a major U.S. stock exchange.
TerrAscend (OTCQX: TSNDF) reported Q1 2026 continuing-operations results: net revenue $65.5M, gross margin 52.8%, GAAP net loss from continuing operations of $6.8M, and Adjusted EBITDA $17.4M (26.5% of revenue). The company generated $8.7M net cash from operations and $7.8M free cash flow.
The quarter marks the 15th consecutive positive operating cash-flow quarter and 11th consecutive quarter of positive free cash flow; cash and equivalents were $39.1M as of March 31, 2026.